Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effect of co-administration of Linggui zhugan decoction and Western medicine on inflammatory cytokines, and immune and cardiac functions of patients with chronic heart failure

He Xin¹, Ji Yunxi²

¹Chinese Internal Medicine of TCM Hospital, AnJi County, Zhejiang Province 313300; ²Chinese Internal Medicine of TCM Zhejiang Province Hospital, Hangzhou City, Zhejiang Province 310002, China.

For correspondence:- Ji Yunxi Email: zy18385@163.com

Accepted: 21 January 2019 Published: 28 February 2019

Citation: Xin H, Yunxi J. Effect of co-administration of Linggui zhugan decoction and Western medicine on inflammatory cytokines, and immune and cardiac functions of patients with chronic heart failure. Trop J Pharm Res 2019; 18(2):365-370 doi: 10.4314/tjpr.v18i2.20

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the combined effect of Linggui zhugan decoction and Western medicine on inflammatory cytokines, and immune and heart functions of patients with chronic heart failure (CHF), and the underlying mechanism(s).

Methods: Patients with CHF (n = 140) were randomly assigned to two groups: control group and study group (70 per group). Patients in the control group were treated with furosemide, metoprolol, spironolactone, isosorbide mononitrate, trimetazidine and irbesartan, once, twice or thrice daily. Study group patients were treated with a combination of Linggui zhugan decoction, in addition to the treatment given to the control group. Levels of inflammatory cytokines, T-lymphocyte subsets and cardiac function were determined by enzyme-linked immunosorbent assay (ELISA), flow cytometry and color Doppler echocardiography, as appropriate. Clinical effectiveness for the two groups were also assessed.

Results: Following the treatments, the serum levels of interleukin-6 (IL-6), interleukins-18 (IL-18) and tumor necrosis factor α (TNF-α) significantly decreased in the study group, when compared with the control group (p < 0. 05). However, the study group had markedly higher levels of CD3+ T, CD4+ T, and CD4+ T /CD8+ T than the control group (p < 0. 05). In addition, CD8+ T was significantly lower in the study group than in control group (p < 0. 05). Patients in the study group had significantly higher total treatment effectiveness than those in the control group (p < 0. 05).

Conclusion: These results suggest that co-administration of decoction of Linggui zhugan and western medicine improves ventricular function and reduces clinical symptoms in patients with CHF via a mechanism involving inhibition of inflammatory reactions.

Keywords: Chronic heart failure, Linggui zhugan decoction, Inflammatory cytokines, T- lymphocyte subsets, Cardiac function